Tag: Cancer

Princess Kate revealed she is undergoing treatment for a cancer diagnosis. What is preventative chemotherapy?
Health

Princess Kate revealed she is undergoing treatment for a cancer diagnosis. What is preventative chemotherapy?

Catherine, the Princess of Wales, announced Friday that doctors discovered cancer in tests conducted after she underwent major abdominal surgery in January. The 42-year-old princess is now undergoing a course of preventative chemotherapy as advised by her medical team, she said in a video. Here is what that may involve.What is preventative chemotherapy?Preventative chemotherapy, which is usually referred to as "adjuvant chemotherapy," is an early treatment that is used to reduce the chance of cancer returning, even if all visible cancer was removed in a surgery, according to the Mayo Clinic.When cancer is removed from the body, there is always a chance undetectable microscopic bits of cancer remain and could grow. This treatment is meant to wipe out those tiny cells, CBS News chief medica...
OJ Simpson Death Cause: OJ Simpson, former American footballer, dies at 76 due to cancer |
Entertainment

OJ Simpson Death Cause: OJ Simpson, former American footballer, dies at 76 due to cancer |

O.J. Simpson, the former NFL star and actor who was at the centre of one of the most sensational trials in American history, has died at the age of 76 after battling cancer. Simpson, famously acquitted of the murder of his ex-wife Nicole Brown Simpson and her friend Ronald Goldman in 1995, passed away in Las Vegas on Wednesday.Simpson's life was known by both legal scandal and athletic success.Before finding success in the NFL (National Football League), he rose to prominence as a college football player and was known as "The Juice" for his exceptional skill on the field. But after his well-reported trial and acquittal on murder charges, his legacy became linked to the legal system.On April 10th, our father, Orenthal James Simpson, succumbed to his battle with cancer.He was surrounded by ...
Princess Kate’s cancer diagnosis raises questions about privacy
Health

Princess Kate’s cancer diagnosis raises questions about privacy

Princess Kate’s cancer diagnosis raises questions about privacy - CBS News Watch CBS News Princess Kate's announcement that she has cancer has led to a reckoning about how the royal family is covered in the press, while also raising questions about what's in store as she requests privacy for her family. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On
Royal expert’s insights on the fallout from Princess Kate’s cancer announcement
Health

Royal expert’s insights on the fallout from Princess Kate’s cancer announcement

Royal expert's insights on the fallout from Princess Kate's cancer announcement - CBS News Watch CBS News CBS News royal contributor Tina Brown joins “CBS Mornings” to talk about Princess Kate's cancer announcement and what it means for the royal family. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On
Doctor explains preventative chemotherapy and what Princess Kate’s recovery could look like
Health

Doctor explains preventative chemotherapy and what Princess Kate’s recovery could look like

Doctor explains preventative chemotherapy and what Princess Kate's recovery could look like - CBS News Watch CBS News Dr. Jon LaPook joins "CBS Mornings" to discuss what preventative chemotherapy means and what Princess Kate's recovery could look like. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On
Startups Are Using AI to Predict Responses to Cancer Drugs
World

Startups Are Using AI to Predict Responses to Cancer Drugs

Dec. 28, 2023 12:01 pm ET|WSJ ProBiomedical startups are using artificial intelligence to predict the response patients will have to cancer treatments, aiming to increase the success of drugs in clinical trials and tailor therapies to individuals.As data accumulate from clinical trials and fields such as gene and protein research, AI is helping scientists sift through large volumes of information to uncover signatures that correlate with response—or resistance—to treatment. Startups are using it to predict which drugs are likely to work in clinical studies and create tests to help doctors choose treatments.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?
Money

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

In pharma, you can take a larger slice of the healthcare pie than your peers, but you are still constrained by the size of the pie. No matter how good your cancer or diabetes drug is, healthcare systems will still have to keep paying for heart disease and rheumatoid arthritis treatments too.That, in a nutshell, is why the divergence of obesity-diabetes companies from the rest of the industry in recent years can’t go on forever. In 2023, Eli Lilly and Novo Nordisk have risen more than 50% each, to become the two largest pharma companies by market capitalization, with their combined value now hovering around $1 trillion. By comparison, the rest of the industry badly underperformed the market, with the NYSE Arca Pharmaceutical Index rising a measly 4% compared with 24% for the S&P 500.  ...
Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion
World

Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion

Updated Dec. 26, 2023 12:33 pm ETDrug company Bristol-Myers Squibb struck a $4.1 billion deal to buy RayzeBio, in a bet on a re-emerging cancer drug technology. RayzeBio develops radiopharmaceutical drugs, which use targeted forms of radiation that are delivered directly to cancer cells. Earlier products using the technology struggled commercially, but further research led to another wave of promising therapies that can attack tumors while limiting damage to surrounding healthy cells. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion
World

Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion

Updated Dec. 26, 2023 12:19 pm ETDrug company Bristol-Myers Squibb struck a $4.1 billion deal to buy RayzeBio, in a bet on a re-emerging cancer drug technology. RayzeBio develops radiopharmaceutical drugs, which use targeted forms of radiation that are delivered directly to cancer cells. Earlier products using the technology struggled commercially, but further research led to another wave of promising therapies that can attack tumors while limiting damage to surrounding healthy cells. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
$19 Billion in a Week: AbbVie Makes Two Big Bets
Money

$19 Billion in a Week: AbbVie Makes Two Big Bets

Early last week, AbbVie was on every healthcare investment banker’s list. But with two quick deal announcements under its belt in just six days, AbbVie may have transformed its pipeline in cancer and neurology and satiated its deal-making hunger.The Chicago-area company, best known for selling Botox and immune-disease drug Humira, announced on Thursday of last week it would pay $10.1 billion for biotech ImmunoGen. On Wednesday, it followed up with the acquisition of Cerevel Therapeutics for $8.7 billion.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8